Search details
1.
Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis.
Ann Intern Med
; 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38830219
2.
Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial Intelligence.
J Urol
; 211(4): 575-584, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38265365
3.
Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma.
J Urol
; : 101097JU0000000000004030, 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38813884
4.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
J Urol
; 211(4): 526-532, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38421252
5.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy.
J Urol
; 211(4): 509-517, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38421253
6.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
J Urol
; 211(4): 518-525, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38421243
7.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Article
in English
| MEDLINE | ID: mdl-38704840
8.
The prevalence of impostor phenomenon and its association with burnout amongst urologists.
BJU Int
; 133(5): 579-586, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38378021
9.
Diagnostic Imaging in the Evaluation of Asymptomatic Microhematuria: Systematic Review and Meta-analysis.
J Urol
; 209(6): 1099-1106, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36883858
10.
The Impact of Medicare Low-income Subsidy on Access to Treatment, Treatment Choice, and Oncologic Outcomes in Patients With Metastatic Prostate Cancer.
J Urol
; 210(3): 447-453, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37341420
11.
Intraoperative Blood Transfusion Is Associated With Increased Risk of Venous Thromboembolism After Radical Cystectomy.
J Urol
; 209(3): 525-531, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36445045
12.
Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model.
J Urol
; 209(1): 89-98, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36067373
13.
The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma.
J Urol
; 210(4): 611-618, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37338930
14.
Coping Mechanisms for Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Survey-based Assessment.
J Urol
; 210(2): 290-298, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37416955
15.
Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study.
J Urol
; 209(3): 515-524, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36475808
16.
Efficacy of RestoreX after prostatectomy: open-label phase of a randomized controlled trial.
BJU Int
; 132(2): 217-226, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37088866
17.
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy.
Int J Urol
; 30(1): 63-69, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36349904
18.
Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data.
Cancer
; 128(24): 4194-4202, 2022 12 15.
Article
in English
| MEDLINE | ID: mdl-36251574
19.
Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors.
J Urol
; 208(5): 960-968, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35748729
20.
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer.
J Urol
; 208(6): 1240-1249, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36349914